DocGo (NASDAQ:DCGO) Given New $6.50 Price Target at Stifel Nicolaus

DocGo (NASDAQ:DCGO) had its price objective cut by investment analysts at Stifel Nicolaus from $8.00 to $6.50 in a report released on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ target price points to a potential upside of 79.56% from the stock’s current price.

Several other brokerages have also recently weighed in on DCGO. Cantor Fitzgerald decreased their price target on shares of DocGo from $13.00 to $11.00 and set an “overweight” rating for the company in a research note on Thursday, February 29th. BTIG Research decreased their target price on shares of DocGo from $13.00 to $11.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Canaccord Genuity Group decreased their target price on shares of DocGo from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Thursday, April 11th. Finally, Needham & Company LLC decreased their target price on shares of DocGo from $14.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, February 29th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $10.58.

DocGo Stock Up 0.3 %

Shares of DCGO opened at $3.62 on Tuesday. The stock has a market capitalization of $377.10 million, a P/E ratio of 51.71, a P/E/G ratio of 0.36 and a beta of 0.91. DocGo has a twelve month low of $2.78 and a twelve month high of $10.82. The company has a 50 day moving average of $3.71 and a 200-day moving average of $4.53.

DocGo (NASDAQ:DCGO) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.13 by ($0.07). The business had revenue of $199.25 million for the quarter, compared to the consensus estimate of $195.48 million. DocGo had a return on equity of 2.01% and a net margin of 1.10%. On average, sell-side analysts anticipate that DocGo will post 0.35 earnings per share for the current fiscal year.

Insider Activity at DocGo

In related news, Director Michael J. Burdiek acquired 10,000 shares of DocGo stock in a transaction on Thursday, March 14th. The stock was purchased at an average cost of $3.61 per share, with a total value of $36,100.00. Following the completion of the transaction, the director now directly owns 571,595 shares in the company, valued at approximately $2,063,457.95. The purchase was disclosed in a document filed with the SEC, which is available through this link. 13.78% of the stock is owned by company insiders.

Hedge Funds Weigh In On DocGo

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Deerfield Management Company L.P. Series C lifted its holdings in shares of DocGo by 55.7% during the third quarter. Deerfield Management Company L.P. Series C now owns 4,764,000 shares of the company’s stock worth $25,392,000 after buying an additional 1,705,000 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of DocGo by 1.2% during the third quarter. Vanguard Group Inc. now owns 4,672,582 shares of the company’s stock worth $24,905,000 after buying an additional 55,246 shares in the last quarter. WCM Investment Management LLC lifted its holdings in shares of DocGo by 1.7% during the first quarter. WCM Investment Management LLC now owns 2,627,032 shares of the company’s stock worth $10,613,000 after buying an additional 44,359 shares in the last quarter. Emerald Advisers LLC lifted its holdings in shares of DocGo by 6.4% during the third quarter. Emerald Advisers LLC now owns 2,406,714 shares of the company’s stock worth $12,828,000 after buying an additional 145,163 shares in the last quarter. Finally, Punch & Associates Investment Management Inc. lifted its holdings in shares of DocGo by 4.4% during the third quarter. Punch & Associates Investment Management Inc. now owns 2,055,359 shares of the company’s stock worth $10,955,000 after buying an additional 85,860 shares in the last quarter. 56.44% of the stock is owned by institutional investors.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.